1. Home
  2. Category
  3. Cancer Type

Prostate Cancer

Article

Involvement in Decision Making and Satisfaction With Treatment Among Partners of Patients With Newly Diagnosed Localized Prostate Cancer

Yael Symes
Lixin Song
Rachael G. Heineman
Brittney D. Barbosa
Kimberly Tatum
Giselle Greene
Mark Weaver
Ronald C. Chen
ONF 2015, 42(6), 672-679 DOI: 10.1188/15.ONF.672-679
Purpose/Objectives: To examine partner involvement in treatment decision making for localized prostate cancer, congruence between partner involvement and patient preference, reasons for partner noninvolvement, and partner satisfaction with patient treatment. Design: Cross-sectional exploratory...
0
No votes yet
Read this Article
Article

Resistance Exercise Reduces Body Fat and Insulin During Androgen-Deprivation Therapy for Prostate Cancer

Kerri M. Winters-Stone
Nathan Dieckmann
Gianni F. Maddalozzo
Jill A. Bennett
Christopher W. Ryan
Tomasz M. Beer
ONF 2015, 42(4), 348-356 DOI: 10.1188/15.ONF.348-356
Purpose/Objectives: To determine whether exercise could reduce biomarkers of cancer progression in prostate cancer survivors (PCSs) on androgen-deprivation therapy (ADT). Design: Randomized, controlled trial. Setting: Oregon Health and Science University School of Nursing. Sample: 51 PCSs...
0
No votes yet
Read this Article
Article

A Qualitative Study Exploring the Perceptions of Sedentary Behavior in Prostate Cancer Survivors Receiving Androgen-Deprivation Therapy

Linda Trinh
Kelly P. Arbour-Nicitopoulos
Catherine M. Sabiston
Shabbir M. Alibhai
Jennifer M. Jones
Scott R. Berry
Andrew Loblaw
Guy E. Faulkner
ONF 2015, 42(4), 398-406 DOI: 10.1188/15.ONF.398-406
Purpose/Objectives: To describe and understand the perceptions of sedentary behavior (SED) and the interests and preferences for a SED intervention of men on androgen-deprivation therapy (ADT) within a two-phase (formative and intervention research) feasibility study. Research Approach: Qualitative...
0
No votes yet
Read this Article
Article

Optimizing the Efficiency and Quality of Sipuleucel-T Delivery in an Academic Institution

Kristen Davis
Sarah Wood
Emily Dill
Yuri Fesko
Rhonda L. Bitting
Michael R. Harrison
Andrew J. Armstrong
Judd W. Moul
Daniel J. George
CJON 2015, 19(3), 297-303 DOI: 10.1188/15.CJON.297-303
Background: Sipuleucel-T, an autologous cellular immunotherapy, is approved for the treatment of certain patients with metastatic castration-resistant prostate cancer (mCRPC). Sipuleucel-T is the first personalized treatment for prostate cancer to be manufactured using the immune system of each...
5
Average: 5 (1 vote)
Read this Article
Online Exclusive Article

Nursing Management of Patients With Castration-Resistant Prostate Cancer Undergoing Radium-223 Dichloride Treatment

Anthony Delacruz
Gabrielle Arauz
Tracy Curley
Amabella Lindo
Trine Jensen
CJON 2015, 19(2), E31-E35 DOI: 10.1188/15.CJON.E31-E35
Background: Radium-223 dichloride, or radium-223, is a first-in-class alpha emitter that selectively targets bone metastases with high-energy, short-range alpha particles and is approved for the treatment of patients with castration-resistant prostate cancer (CRPC), symptomatic bone metastases, and...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.